Results 21 to 30 of about 2,013,224 (205)

MDCT imaging in malignant carcinoid syndrome [PDF]

open access: yesIndian Journal of Gastroenterology, 2011
A 65-year-old lady presented with sudden onset of palpitations, headache, perspirations and flushing. Clinical examination revealed tenderness in right lumbar region. Ultrasound abdomen revealed multiple hyperechoic hepatic lesions and a mesenteric mass.
Kamini, Gupta   +3 more
openaire   +2 more sources

A Case of Pulmonary Carcinoid Tumor with a Superimposed Aspergilloma Presenting As a Covert Ectopic Adrenocorticotropic Hormone Syndrome

open access: yesFrontiers in Endocrinology, 2017
Ectopic adrenocorticotropic hormone (ACTH) syndrome is a challenging diagnosis only responsible for approximately 10% of Cushing syndrome cases. It has been associated with a variety of benign and malignant tumors including a carcinoid tumor accompanied ...
Kyoung Jin Kim   +5 more
doaj   +1 more source

Malignancy within a Tail Gut Cyst: A Case of Retrorectal Carcinoid Tumour [PDF]

open access: yes, 2014
Purpose. Tailgut cysts with malignant transformation are rare entities. We discuss the diagnostic strategy and treatment of a malignancy within a tailgut cyst. Methods.
Abukar, AA   +23 more
core   +1 more source

High-Dose Lanreotide in the Treatment of Poorly Differentiated Pancreatic Neuroendocrine Carcinoma: A Case Report

open access: yesCase Reports in Oncology, 2014
Pancreatic neuroendocrine tumors (NETs), including poorly differentiated carcinomas (NECs), are rarely encountered. The majority of these tumors do not secrete excess hormones, but functioning NETs produce large amounts of vasoactive peptides and may ...
Frank Van Fraeyenhove   +7 more
doaj   +1 more source

Targeted treatment with somatostatin analogues: widening horizons of clinical practice

open access: yesAlʹmanah Kliničeskoj Mediciny, 2022
Targeted treatment with somatostatin analogues (SA) in acromegaly and neuroendocrine neoplasms may have some benefits compared to curative treatments, because these agents decrease excessive hormone secretion and exert a tumor-suppressive effect ...
Vyacheslav S. Pronin   +3 more
doaj   +1 more source

Ectopic ACTH Cushing's syndrome caused by a large-cell neuroendocrine lung carcinoma responding to desmopressin

open access: yesEndocrine Oncology, 2023
Ectopic adrenocorticotrophic hormone (ACTH) secretion (EAS) is a rare cause of ACTH-dependent Cushing’s syndrome (CS), most often caused by a thoracic neuroendocrine tumor (NET).
Stéphanie Larose   +3 more
doaj   +1 more source

Serotoninergic brain dysfunction in neuroendocrine tumor patients: A scoping review

open access: yesComprehensive Psychiatry, 2021
Introduction: Neuroendocrine tumors (NETs) are rare and malignant neoplasms characterized by their potential to produce metabolically active substances with the capacity to bring about clinical syndromes.
Anna La Salvia   +8 more
doaj   +1 more source

Beyond Nature's Blueprint: Macrocyclic Peptides Containing Unnatural Amino Acids in Therapeutic Development

open access: yesAngewandte Chemie, Volume 138, Issue 45, 2 November 2026.
Strategic incorporation of unnatural amino acids transforms macrocyclic peptides into drug‐like molecules capable of engaging challenging targets. These building blocks enhance stability, permeability, and bioavailability, accelerating the development of next‐generation peptide therapeutics.
Krishna K. Sharma   +5 more
wiley   +2 more sources

Year in Review 2018 by the Brazilian Gastrointestinal Tumors Group: Neuroendocrine Tumors

open access: yesBrazilian Journal of Oncology, 2018
Neuroendocrine tumors (NET) constitute a heterogeneous group of neoplasms with variable prognoses and clinical presentations. Therefore their therapeutic management is challenging, involving a real multidisciplinary approach composed of medical ...
Duilio R. Rocha   +2 more
doaj   +1 more source

Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies [PDF]

open access: yes, 2023
Carcinoid syndrome represents a debilitating paraneoplastic disease, caused by the secretion of several substances, occurring in about 10–40% of patients with well-differentiated neuroendocrine tumors (NETs).
Federica Campolo   +17 more
core   +1 more source

Home - About - Disclaimer - Privacy